#gsk — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gsk, aggregated by home.social.
-
GSK Lands Its First Lung Cancer Drug Days After Nuvalent Deal Closes — BigGo Finance
GSK had never won FDA approval for a lung cancer drug — not in decades of trying. Then,…
#EuropeSays #Britain #Europe #EU #GSK #AxiomBiosciences #FDA #FierceBiotech #HongKongExchange #Jideytro #MarissaRusso #nasdaq #Nuvalent #TheTopLine #U.S.HouseofRepresentatives
https://www.europesays.com/britain/89781/ -
https://www.europesays.com/britain/89781/ GSK Lands Its First Lung Cancer Drug Days After Nuvalent Deal Closes — BigGo Finance #AxiomBiosciences #FDA #FierceBiotech #GSK #HongKongExchange #Jideytro #MarissaRusso #nasdaq #Nuvalent #TheTopLine #USHouseOfRepresentatives
-
GSK admits 70,759 new shares to London market | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #admissiontotrading #blocklisting #Form6-K #GSKplc #LondonStockExchange #ordinaryshares #ShareSavePlan2022
https://www.europesays.com/britain/89766/ -
https://www.europesays.com/britain/89766/ GSK admits 70,759 new shares to London market | GSK SEC Filing #AdmissionToTrading #BlockListing #Form6K #GSK #GSKPlc #LondonStockExchange #OrdinaryShares #ShareSavePlan2022
-
GSK (LSE:GSK) Stock Still Looks Undervalued As Jideytro Wins FDA Approval
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
#EuropeSays #Britain #Europe #EU #GSK #GSKstock #stockportfolio
https://www.europesays.com/britain/89749/ -
https://www.europesays.com/britain/89749/ GSK (LSE:GSK) Stock Still Looks Undervalued As Jideytro Wins FDA Approval #GSK #GSKStock #StockPortfolio
-
GSK executive acquires 9.4 notional ADS in plan | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #ADS #AmericanDepositaryShares #executivesupplementalsavingsplan #Form6-K #GSKplc #insidertransaction #MayaMartinez-Davis #NYSE
https://www.europesays.com/britain/89735/ -
https://www.europesays.com/britain/89735/ GSK executive acquires 9.4 notional ADS in plan | GSK SEC Filing #ADS #AmericanDepositaryShares #ExecutiveSupplementalSavingsPlan #Form6K #GSK #GSKPlc #InsiderTransaction #MayaMartinezDavis #NYSE
-
https://www.europesays.com/britain/?p=89719 Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data #acquisition #AdenoAssociatedVirus #DidNotMeetEndpoint #DiscontinueTheStudy #European UnionApproval #FDA #FDA510(k)Clearance #FirstLungCancerTherapy #GeneTherapy #GSK #HNSCC #Keytruda #Layoff #merge #MultipleMyeloma #Obesity #PDUFA #ReusableSpO2ClipSensor #Type2Daibetes
-
https://www.europesays.com/britain/?p=89701 GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Canada #ClinicalTrials&MedicalDiscoveries #GlaxoSmithKlineInc #GSK #HealthCare&Hospitals #InfectionControl #InternationalMedicalApproval #MedicalPharmaceuticals #Pharmaceuticals
-
https://www.europesays.com/britain/89681/ Shell & GSK: Stock market week ahead – 27-31 July #GSK #StandardArticle #Stocks&Shares #TheStockMarketWeekAhead
-
Rx Rundown: Samsung Biologics, Dimension, GSK and more
Deals: Samsung Biologics to buy Swiss PolyPeptide Group in a $1.8 billion deal. Tempus bought out cancer genomics…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/89605/ -
https://www.europesays.com/britain/89605/ Rx Rundown: Samsung Biologics, Dimension, GSK and more #GSK
-
GSK (LSE:GSK) Could Be 10% Undervalued On Jideytro FDA Approval
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
#EuropeSays #Britain #Europe #EU #GSK #non-smallcelllungcancer #shareprice #totalshareholderreturn
https://www.europesays.com/britain/89589/ -
GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Canada
Prefilled syringe offers healthcare professionals a convenient administration option New presentation will begin rolling out across Canada in…
#EuropeSays #Britain #Europe #EU #GSK #AdvisoryCommitteeonImmunizationPractices #Canada #CardiovascularDisease #chronicconditions #healthcareprofessionals #Prefilledsyringe #presentation #shingles #vaccineadministration #ZosterVaccine
https://www.europesays.com/britain/89567/ -
https://www.europesays.com/britain/89567/ GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Canada #AdvisoryCommitteeOnImmunizationPractices #Canada #CardiovascularDisease #ChronicConditions #GSK #HealthcareProfessionals #PrefilledSyringe #presentation #shingles #VaccineAdministration #ZosterVaccine
-
‘I had dreams’: How HIV care has evolved across a generation
In 2025, almost 41 million people were living with HIV worldwide, according to UNAIDS, with over half living…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/89539/ -
https://www.europesays.com/britain/89539/ ‘I had dreams’: How HIV care has evolved across a generation #GSK
-
GSK (LSE:GSK) Stock Still Looks Undervalued As Jideytro Wins FDA Approval
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
#EuropeSays #Britain #Europe #EU #GSK #GSKstock #stockportfolio
https://www.europesays.com/britain/89514/ -
https://www.europesays.com/britain/89514/ GSK (LSE:GSK) Stock Still Looks Undervalued As Jideytro Wins FDA Approval #GSK #GSKStock #StockPortfolio
-
How Consumer Stocks Are Reading Today Through GSK (LSE:GSK) And Wider Risk Signals
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions,…
#EuropeSays #Britain #Europe #EU #GSK #HowConsumerStocksAreReadingTodayThroughGSK(LSE:GSK)AndWiderRiskSignals
https://www.europesays.com/britain/89441/ -
https://www.europesays.com/britain/89441/ How Consumer Stocks Are Reading Today Through GSK (LSE:GSK) And Wider Risk Signals #GSK #HowConsumerStocksAreReadingTodayThroughGSK(LSE:GSK)AndWiderRiskSignals
-
Samsung Biologics First-Half Operating Profit Tops ₩1 Trillion; Annual Revenue of ₩5 Trillion Within Reach — BigGo Finance
Samsung Biologics (207940) has surpassed ₩1 trillion (approximately $678.2 million) in half-year operating profit for the first time…
#EuropeSays #Korea #KR #SamsungBiologics #BioCampus3 #Celltrion #GLP-1 #GSK #JohnRim #Netherlandssalesoffice #peptide #Plant5 #PolyPeptideGroup #Rockvilleproductionfacility #Samsung
https://www.europesays.com/korea/97114/ -
How Consumer Stocks Are Reading Today Through GSK (LSE:GSK) And London Risk Signals
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions,…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/89349/ -
https://www.europesays.com/britain/89349/ How Consumer Stocks Are Reading Today Through GSK (LSE:GSK) And London Risk Signals #GSK
-
GSK shelves cough drug acquired in $2B deal
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
#EuropeSays #Britain #Europe #EU #GSK #chroniccough #coughmedicine #irritablebowelsyndrome #TreviTherapeutics
https://www.europesays.com/britain/89320/ -
https://www.europesays.com/britain/89320/ GSK shelves cough drug acquired in $2B deal #ChronicCough #CoughMedicine #GSK #IrritableBowelSyndrome #TreviTherapeutics
-
Is GSK (LSE:GSK) Undervalued Following Jideytro Approval?
The latest move in GSK (LSE:GSK) stock interest is tied to the early US FDA approval of Jideytro…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/89306/ -
https://www.europesays.com/britain/89306/ Is GSK (LSE:GSK) Undervalued Following Jideytro Approval? #GSK
-
GSK (LSE:GSK) Wins FDA Nod For Jideytro As Bexsero And Jemperli Advance
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
#EuropeSays #Britain #Europe #EU #GSK #Bexsero #Jemperli #Jideytro #Lungcancer #meningococcaldisease #Oncology #rectalcancer
https://www.europesays.com/britain/89247/ -
https://www.europesays.com/britain/89247/ GSK (LSE:GSK) Wins FDA Nod For Jideytro As Bexsero And Jemperli Advance #Bexsero #GSK #Jemperli #Jideytro #LungCancer #MeningococcalDisease #Oncology #RectalCancer
-
GSK secures first lung cancer approval, validating $10.6bn Nuvalent bet
Just days after completing a $10.6bn takeover of lung cancer biotech Nuvalent, GSK is already reaping the rewards…
#EuropeSays #Britain #Europe #EU #GSK #acquisition #brainmetastases #kinaseinhibitor #Lungcancer #Nuvalent #resistancemutations #USFoodandDrugAdministration
https://www.europesays.com/britain/89008/ -
https://www.europesays.com/britain/89008/ GSK secures first lung cancer approval, validating $10.6bn Nuvalent bet #acquisition #BrainMetastases #GSK #KinaseInhibitor #LungCancer #Nuvalent #ResistanceMutations #USFoodAndDrugAdministration
-
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
Approval based on ARROS-1 phase I/II trial demonstrating meaningful and durable responses in patients with locally advanced or…
#EuropeSays #Britain #Europe #EU #GSK #Biotechnology #ClinicalTrials&MedicalDiscoveries #FDAapproval #GSKplc #HealthCare&Hospitals #MedicalEquipment #MedicalPharmaceuticals #Pharmaceuticals
https://www.europesays.com/britain/88598/ -
https://www.europesays.com/britain/88598/ Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer #Biotechnology #ClinicalTrials&MedicalDiscoveries #FDAApproval #GSK #GSKPlc #HealthCare&Hospitals #MedicalEquipment #MedicalPharmaceuticals #Pharmaceuticals
-
$10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval
A drug included in one of the pharmaceutical industry’s largest acquisitions this year is starting to paying dividends…
#EuropeSays #Britain #Europe #EU #GSK #biopharmanl #Cancer #ClinicalTrials #FDA #Lungcancer #non-smallcelllungcancer #Nuvalent #Spotlight-payeropp
https://www.europesays.com/britain/88582/ -
FDA Greenlights GSK’s First Lung Cancer Drug Ahead of Schedule – GSK (NYSE:GSK)
On Wednesday, the U.S. Food and Drug Administration (FDA) granted early approval to GSK plc’s (NYSE:GSK) targeted lung…
#EuropeSays #Britain #Europe #EU #GSK #category:Biotech #category:FDA #category:General #category:HealthCare #category:LargeCap #category:News #CMS:WordPress #PageIsBzPro:BZ #symbol:GSK
https://www.europesays.com/britain/88336/ -
A-Alpha Bio Announces Industry-First Data Consortium to Solve AI Protein Engineering’s Experimental Data Bottleneck. Founding members include GSK, Boltz, Cradle, and Dyno Therapeutics.
Consortium members will steer the experimental design with A-Alpha Bio to generate the large-scale, standardized antibody-antigen affinity and…
#EuropeSays #Britain #Europe #EU #GSK #A-Alpha #ai #Announces #Bio #Consortium #Data #engineering #Industry-First #protein #Solve #to
https://www.europesays.com/britain/88078/ -
https://www.europesays.com/britain/88078/ A-Alpha Bio Announces Industry-First Data Consortium to Solve AI Protein Engineering’s Experimental Data Bottleneck. Founding members include GSK, Boltz, Cradle, and Dyno Therapeutics. #AAlpha #ai #Announces #Bio #Consortium #Data #engineering #GSK #IndustryFirst #protein #Solve #to
-
https://www.europesays.com/britain/87919/ GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release #ConsensusEPSEstimate #ConsensusEstimate #ConsensusOutlook #EarningsRelease #EarningsReport #EarningsWhisper #GSK #ZacksRank
-
By mid-2027, analysts expect £6,000 in GSK shares to be worth…
After a major move higher in the second half of 2025 and early 2026, GSK (LSE: GSK) shares…
#EuropeSays #Britain #Europe #EU #GSK #analysts #FTSE100index #GSKplc #GSKshares #Johnson&Johnson #pricetarget #pricetargets #shareprice
https://www.europesays.com/britain/87213/ -
https://www.europesays.com/britain/87213/ By mid-2027, analysts expect £6,000 in GSK shares to be worth… #analysts #FTSE100Index #GSK #GSKPlc #GSKShares #Johnson&Johnson #PriceTarget #PriceTargets #SharePrice
-
GSK seeks EMA label update for Bexsero booster | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE…
#EuropeSays #Britain #Europe #EU #GSK #Bexserobooster #biopharma #EuropeanMedicinesAgency #Form6-K #GSKstock #invasivemeningococcaldisease #serogroupBvaccine
https://www.europesays.com/britain/86840/ -
Halifax
Important information Halifax Share Dealing Limited. Registered in England and Wales no. 3195646. Registered Office: Trinity Road, Halifax,…
#EuropeSays #Britain #Europe #EU #GSK #BrokerOnLine
https://www.europesays.com/britain/86383/ -
EMA Accepts GSK’s Bexsero Booster Label Update for Single-Dose Meningitis B Vaccine in Individuals Aged 10 and Above
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions,…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/86370/ -
GSK Discontinues Development of Camlipixant for Refractory Chronic Cough
GSK plc GSK has announced that it is discontinuing development of camlipixant, an investigational P2X3 receptor antagonist, for the…
#EuropeSays #Britain #Europe #EU #GSK #chroniccough #development #EPSestimates #GSKplc #ZacksInvestmentResearch
https://www.europesays.com/britain/85910/ -
https://www.europesays.com/britain/85910/ GSK Discontinues Development of Camlipixant for Refractory Chronic Cough #ChronicCough #development #EPSEstimates #GSK #GSKPlc #ZacksInvestmentResearch
-
GSK ends camlipixant RCC program after mixed results | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #BALANCEtrial #CALM-1 #CALM-2 #camlipixant #GSKplc #IBS-D #PhaseIIItrials #refractorychroniccough #SECForm6-K
https://www.europesays.com/britain/85320/ -
https://www.europesays.com/britain/85310/ GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough #BellusHealth #BiopharmaNl #ChronicCough #ClinicalTrials #GSK #respiratory